Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IIN
2626
DELISTED
IntriCon Corporation
IIN
| $882K | ﹤0.01% |
33,425
+7,846
| +31% | +$298K |
|
2627
State Street SPDR S&P Metals & Mining ETF
XME
$4.83B
| $879K | ﹤0.01% |
33,567
+17,480
| +109% | +$528K |
|
|
HIO
2628
Western Asset High Income Opportunity Fund
HIO
$332M
| $878K | ﹤0.01% |
200,514
-4,984
| -2% | -$22.7K |
|
2629
Hackett Group
HCKT
$278M
| $877K | ﹤0.01% |
54,779
-58,572
| -52% | -$1.09M |
|
|
SNCR
2630
DELISTED
Synchronoss Technologies
SNCR
| $877K | ﹤0.01% |
+15,867
| New | +$872K |
|
2631
Yeti Holdings
YETI
$3.11B
| $877K | ﹤0.01% |
+59,090
| New | +$937K |
|
|
HYI
2632
Western Asset High Yield Opportunity Fund Inc
HYI
$133M
| $875K | ﹤0.01% |
66,540
+1,540
| +2% | +$21.4K |
|
2633
Manhattan Associates
MANH
$12.4B
| $875K | ﹤0.01% |
20,660
-184,103
| -90% | -$8.72M |
|
|
KDMN
2634
DELISTED
Kadmon Holdings, Inc.
KDMN
| $873K | ﹤0.01% |
+419,657
| New | +$1.06M |
|
|
GWR
2635
DELISTED
Genesee & Wyoming Inc.
GWR
| $873K | ﹤0.01% |
+11,789
| New | +$945K |
|
2636
Axsome Therapeutics
AXSM
$10.8B
| $871K | ﹤0.01% |
+308,802
| New | +$1.02M |
|
2637
CALL
CF Industries
CF
$19.3B
| $870K | ﹤0.01% |
20,000
+6,000
| +43% | +$281K |
|
2638
Powell Industries
POWL
$6.93B
| $868K | ﹤0.01% |
104,073
+47,955
| +85% | +$475K |
|
2639
CALL
Globus Medical
GMED
$11.1B
| $866K | ﹤0.01% |
+20,000
| New | +$998K |
|
2640
Wipro
WIT
$18.6B
| $866K | ﹤0.01% |
449,949
+251,488
| +127% | +$483K |
|
|
HAYN
2641
DELISTED
Haynes International, Inc.
HAYN
| $866K | ﹤0.01% |
32,785
-1,550
| -5% | -$48K |
|
2642
ATN International
ATNI
$473M
| $864K | ﹤0.01% |
12,076
-12,685
| -51% | -$991K |
|
2643
VanEck High Yield Muni ETF
HYD
$4.36B
| $862K | ﹤0.01% |
14,129
-4,068
| -22% | -$248K |
|
|
NRCG
2644
DELISTED
NRC Group Holdings Corp.
NRCG
| $856K | ﹤0.01% |
+111,856
| New | +$958K |
|
|
PDLI
2645
DELISTED
PDL BioPharma, Inc.
PDLI
| $852K | ﹤0.01% |
293,842
+92,697
| +46% | +$255K |
|
2646
ProShares Short VIX Short-Term Futures ETF
SVXY
$246M
| $846K | ﹤0.01% |
+40,000
| New | +$983K |
|
2647
Hain Celestial
HAIN
$78.9M
| $845K | ﹤0.01% |
53,260
-456,015
| -90% | -$10.2M |
|
2648
Ocular Therapeutix
OCUL
$2.39B
| $837K | ﹤0.01% |
210,273
+50,118
| +31% | +$276K |
|
2649
RadNet
RDNT
$6.05B
| $837K | ﹤0.01% |
82,339
+65,138
| +379% | +$884K |
|
|
CMRX
2650
DELISTED
Chimerix, Inc.
CMRX
| $837K | ﹤0.01% |
325,650
+66,014
| +25% | +$221K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.